¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Calcium deposit in bursa"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • interosseous cubital bursa
    À§ÆÈµÎ°¥·¡±Ù³ëÁÖ¸Ó´Ï, À§ÆÈµÎ°¥·¡±Ù³ëÀ±È°³¶
  • lateral gastrocnemius bursa
    °¡ÂÊÀåµýÁö±ÙÁÖ¸Ó´Ï, ¿ÜÃøºñº¹±Ù³¶
  • omental bursa
    ±×¹°¸·ÁÖ¸Ó´Ï, ¸Á³¶
  • popliteal bursa
    ¿À±Ý±Ù¹ØÁÖ¸Ó´Ï, ½½¿Í±ÙÇϳ¶
  • prepatellar bursa
    ¹«¸­¾ÕÀ±È°ÁÖ¸Ó´Ï, ½½°³Àü³¶
  • pharyngeal bursa
    ÀÎµÎÆíµµÁÖ¸Ó´Ï, Àεγ¶
  • radial bursa
    ³ëÂÊÈûÁÙÁý, ¿äÃøÈ°¾×³¶
  • retrohyoid bursa
    ¸ñ»ÔµÚÀ±È°ÁÖ¸Ó´Ï, ¼³°ñÈij¶
  • subacromial bursa
    ºÀ¿ì¸®¹ØÁÖ¸Ó´Ï, °ßºÀÇϳ¶
  • subcutaneous acromial bursa
    ºÀ¿ì¸®ÇǺιØÁÖ¸Ó´Ï, ¾î±úºÀ¿ì¸®ÇǺιØÁÖ¸Ó´Ï, ÇÇÇϰߺÀ³¶
  • subcutaneous bursa
    ÇǺιØÁÖ¸Ó´Ï, ÇÇÇϳ¶
  • subcutaneous calcaneal bursa
    ¹ß²ÞÄ¡ÇǺιØÁÖ¸Ó´Ï, ÇÇÇÏÁ¾°ñ³¶
  • subcutaneous synovial bursa
    ÇǺιØÁÖ¸Ó´Ï, ÇÇÇÏÀ±È°³¶
  • subcutaneous trochanteric bursa
    ³Ò´Ù¸®Å«µ¹±âÇǺιØÁÖ¸Ó´Ï, ´ëÀüÀÚÇÇÇϳ¶
  • subdeltoid bursa
    ¾î±ú¼¼¸ð±Ù¹ØÁÖ¸Ó´Ï, »ï°¢±ÙÇϳ¶
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • lateral gastrocnemius bursa
    °¡ÂÊÀåµýÁö±ÙÁÖ¸Ó´Ï
  • omental bursa
    ±×¹°¸·ÁÖ¸Ó´Ï
  • pharyngeal bursa
    ÀÎµÎÆíµµÁÖ¸Ó´Ï
  • popliteal bursa
    ¿À±ÝÁÖ¸Ó´Ï
  • prepatellar bursa
    ¹«¸­¾ÕÁÖ¸Ó´Ï
  • radial bursa
    ³ëÂÊÈûÁÙÁý, ¿ä°ñȰ¾×³¶
  • retrohyoid bursa
    ¸ñ»ÔµÚÀ±È°ÁÖ¸Ó´Ï
  • subacromial bursa
    ºÀ¿ì¸®¹ØÁÖ¸Ó´Ï
  • subcutaneous bursa
    ÇǺιØÁÖ¸Ó´Ï, ÇÇÇÏÁÖ¸Ó´Ï
  • subcutaneous acromial bursa
    ºÀ¿ì¸®ÇǺιØÁÖ¸Ó´Ï
  • subcutaneous calcaneal bursa
    ¹ß²ÞÄ¡ÇǺιØÁÖ¸Ó´Ï
  • subcutaneous synovial bursa
    ÇǺιØÁÖ¸Ó´Ï
  • subcutaneous trochanteric bursa
    ³Ò´Ù¸®Å«µ¹±âÇǺιØÁÖ¸Ó´Ï
  • subdeltoid bursa
    ¾î±ú¼¼¸ð±Ù¹ØÁÖ¸Ó´Ï
  • subfascial bursa
    ±Ù¸·¹ØÁÖ¸Ó´Ï
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • immune deposit disease
    ¸é¿ª(±Û·ÎºÒ¸°)Ä§ÂøÁõÈıº.
  • mutton fat deposit
    Áö¹æ¼º Ä§Âø¹°(ò·Û¸àõöØó·Úª).
  • preoperative autologous deposit
    ¼ö¼úÀüÀÚ°¡Ç÷¾×¿¹Ä¡
  • radioactive deposit
    ¹æ»ç´ÉÃàÀû
  • sludge deposit
    ÅðÀû¹°(÷ØîÝÚª).
  • calcium
    Ä®½·
  • calcium
    Ä®½·
  • calcium alterans
    Ä®½·±³´ë( -ÎßÓÛ).
  • calcium antagonist
    Ä®½·±æÇ×Á¦.
  • calcium balance
    Ä®½·ÆòÇü(¡­øÁû¬)
  • calcium bilirubinate crystal
    ºô¸®·çºó»êÄ®½·°áÁ¤
  • calcium carbonate
    ź»êÄ®½·
  • calcium channel
    Ä®½·Åë·Î( -÷×ÖØ).
  • calcium channel
    Ä®½· Åë·Î(÷×ÖØ)
  • calcium channel antagonist,blocker
    Ä®½·Åë·Î ±æÇ×Á¦( -÷×ÖØ ÑÏù÷ð¥),Â÷´ÜÁ¦(ó´Ó¨ð¥).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Ischiadic bursa of obturator internus
    ¼ÓÆó¼â±Ù±ÃµÕÁÖ¸Ó´Ï
    [¿¾ ¿ë¾î] ³»Æó¼â±ÙÁ°ñ³¶
  • Subtendinous bursa of obturator internus
    ¼ÓÆó¼â±ÙÈûÁÙ¹ØÁÖ¸Ó´Ï
    [¿¾ ¿ë¾î] ³»Æó¼â±Ù°ÇÇϳ¶
  • Infracardiac bursa
    ½ÉÀ徯·¡ÁÖ¸Ó´Ï
    [¿¾ ¿ë¾î] ½ÉÇϳ¶
  • Inferior subtendinous bursa of biceps femoris
    ¾Æ·¡³Ò´Ù¸®µÎ°¥·¡±ÙÈûÁÙ¹ØÁÖ¸Ó´Ï
    [¿¾ ¿ë¾î] ÇÏ´ëÅðÀ̵αٰÇÇϳ¶
  • Subcutaneous bursa of medial malleolus
    ¾ÈÂʺ¹»çÇǺιØÁÖ¸Ó´Ï
    [¿¾ ¿ë¾î] ³»°úÇÇÇϳ¶
  • Subtendinous bursa of medial head of gastrocnemius
    ¾ÈÂÊÀåµýÁö±ÙÈûÁÙ¹ØÁÖ¸Ó´Ï
    [¿¾ ¿ë¾î] ºñº¹±Ù³»Ãø°ÇÇϳ¶
  • Subtendinous bursa of tibialis anterior
    ¾ÕÁ¤°­±ÙÈûÁÙ¹ØÁÖ¸Ó´Ï
    [¿¾ ¿ë¾î] Àü°æ°ñ±Ù°ÇÇϳ¶
  • Subtendinous bursa of subscapularis m.
    ¾î±ú¹Ø±ÙÈûÁÙ¹ØÁÖ¸Ó´Ï
    [¿¾ ¿ë¾î] °ß°©ÇϱٰÇÇϳ¶
  • Subdeltoid bursa
    ¾î±ú¼¼¸ð±Ù¹ØÁÖ¸Ó´Ï
    [¿¾ ¿ë¾î] »ï°¢±ÙÇϳ¶
  • Subtendinous iliac bursa
    ¾ûµ¢±ÙÈûÁÙ¹ØÁÖ¸Ó´Ï
    [¿¾ ¿ë¾î] Àå°ñ±Ù°ÇÇϳ¶
  • Superior bursa of biceps femoris
    À§³Ò´Ù¸®µÎ°¥·¡±ÙÁÖ¸Ó´Ï
    [¿¾ ¿ë¾î] »ó´ëÅðÀ̵αٳ¶
  • Bicipitoradial bursa
    À§ÆÈµÎ°¥·¡±Ù³ëÁÖ¸Ó´Ï
    [¿¾ ¿ë¾î] À̵αٿä°ñ³¶
  • Subtendinous bursa of triceps brachii
    À§ÆÈ¼¼°¥·¡±ÙÈûÁÙ¹ØÁÖ¸Ó´Ï
    [¿¾ ¿ë¾î] »ó¿Ï»ïµÎ±Ù°ÇÇϳ¶
  • Synovial bursa
    À±È°ÁÖ¸Ó´Ï
    [¿¾ ¿ë¾î] Ȱ¾×³¶
  • Bursa of tensor veli palatini
    ÀÔõÀå±äÀå±ÙÁÖ¸Ó´Ï
    [¿¾ ¿ë¾î] ±¸°³¹üÀå±Ù³¶
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
ACM acetaminophen; acute cerebrospinal meningitis; Adriamycin, cyclophosphamide, methotrexate; albumin- ...
BCP basic calcium phosphate; birth control pill; blue cone pigment; Blue Cross Plan; bromcresol purple
CA anterior commissure [Lat. commissura anterior]; calcium antagonist; California [rabbit]; cancer; Can...
Ca calcium; cancer, carcinoma; Candida albicans; cathode
Ca2+-blocker calcium channel blocker
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
CPC Calcium Phosphate Cement
CRC Calcium Release Channel
CASR Calcium Sensing Receptor
CA calcium antagonist
CaBP Calcium binding protein
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • calcium levulinate
    ·¹ºÒ¸° »ê Ä®½·
    Ä®½· º¸½ÀÁ¦. ¹é»ö °áÁ¤¼º ¶Ç´Â ¹«Á¤Çü ºÐ¸¸. Ä®½· °áÇÌÁõÀÇ Ä¡·á¿¡ Ä®½· º¸±ÞÁ¦·Î »ç¿ëµÈ´Ù.
  • calcium metabolism
    Ä®½·´ë»ç
    Ç÷ÀåÁßÀÇ Ä®½· ³óµµ¸¦ ÀÏÁ¤ÇÏ°Ô À¯ÁöÇÏ¸ç »ÀÀÇ ¼®È¸È­¸¦ À§ÇÑ Ä®½· °ø±ÞÀ» ÇÏ´Â »ýÈ­ÇÐÀû, »ý¸®ÇÐÀû °úÁ¤.
  • calcium oxide
    »êÈ­ Ä®½·
    ºÎ½Ä¼º ¾ËÄ®¸®, ºÎ½Ä¼º Åä·ùÀÇ ÀÏÁ¾. °ø±âÁßÀÇ ÀÌ»êȭź¼Ò¸¦ Èí¼öÇÏ´Â µ¥ ¾²À̸ç, °ø¾÷ÀûÀ¸·Î´Â °ª½Ñ ¾ËÄ®¸®·Î ±×¸®°í ¸ð¸£Å¸¸£ÀÇ ±âÀç·Î »ç¿ëµÈ´Ù.
  • calcium phosphate
    Àλê Ä®½·
    Ä®½·±â¿Í ÀÎ»ê ±â¸¦ °¡Áø ¿°À¸·Î ¼¼ °¡Áö ÇüŰ¡ ÀÖ´Ù.
  • calcium propionate
    ÇÁ·ÎÇǿ »ê Ä®½·
    ÇÁ·ÎÇǿ »êÀÇ Ä®½·¿°. Ç× Áø±Õ¼ºÀ» °®´Â´Ù. ´Üµ¶À¸·Î ¶Ç´Â ÇÁ·ÎÇǿ »ê ³ªÆ®·ýÀ̳ª ´Ù¸¥ ¿ä¼Ò¿Í °áÇÕÇÏ¿© ¹æºÎÁ¦¿Í ±¹¼ÒÀû Ç× Áø±ÕÁ¦·Î »ç¿ëµÈ´Ù.
  • calcium pyrophosphate dihydrate
    À̼öÈ­ ÇÇ·ÎÀλê Ä®½·
  • calcium salt
    Ä®½· ¿°
  • calcium sulfate
    Ȳ»ê Ä®½·
    õ¿¬ÀûÀ¸·Î¼­ ¼®°í CaSO4, 2H2O ¹× °æ¼®°í CaSO4·Î½á »êÃâ, ÀüÀÚ¸¦ Å¿ö¼­ CaSO4, 1/2H2OÀÇ ¼Ò¼®°í·Î¼­ »ç¿ëÇÑ´Ù. À̰Ϳ¡ ¹°À» °¡ÇÏ¿© Àλóü³»¿¡ ÁÖÀÔ½ÃŰ¸é ¼öºÐ¿¡¼­ 10ºÐ »çÀÌ¿¡ ¼®°í°¡ µÇ°í °æÈ­µÈ´Ù. ¼®°íÀÇ ¿ëÇØµµ´Â 42¡É·Î¼­ ÃÖ°íÀÌ´Ù. ¼®°í ¸ðÇü Á¦ÀÛ µî¿¡ »ç¿ëµÈ´Ù.
  • calcium sulfate bonded investment
    ¼®°í°è ¸Å¸ôÀç, ¼®°í °áÇÕ ¸Å¸ôÀç
  • calcium sulfate hemihydrate
    ¹Ý¼ö ¼®°í
    À̼ö ¼®°í¸¦ °¥¾Æ¼­ 230¡­248¢µÀÇ ¿Âµµ¸¦ °¡ÇÏ¸é °áÁ¤Ã¼ ÁßÀÇ ÀϺΰ¡ »ÀÀÚ ³ª°¡ Ä¡°ú¿ë °æ¼®°í°¡ µÈ´Ù. È­ÇÐ ±¸Á¶½Ä CaSO4, 1/2H2O.
  • calcium-channel blocker
    Ä®½· Â÷´ÜÁ¦, Ä®½· Åë·Î Â÷´ÜÁ¦
  • calcium/phosphorus metabolism
    Ä®½·/ÀÎ ´ë»ç
  • dioctyl calcium sulfosuccinate
    ¼³Æ÷È£¹Ú»ê´ÙÀÌ¿ÁÆ¿ Ä®½·
    ¹é»öÀÇ Á©¶óƾ °°Àº °íü. ¹°¿¡ ¾à°£ ³ìÀ¸¸ç ½ÀÀ±Á¦ ¹× º¯ÀÇ ¿¬È­Á¦·Î »ç¿ëµÈ´Ù.
  • exchangeable calcium
    ±³È¯¼º Ä®½·
    Á¶Á÷ ¼Ó¿¡ ÀÖÀ¸¸é¼­ Ç÷¾× »çÀÌ¿¡ »óÈ£ ±³È¯ °¡´ÉÇÑ Ä®½·.
  • milk of calcium
    ¿ìÀ¯Çü Ä®½·
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
calcium deficiency A low blood calcium (hypocalcaemia) makes the nervous system highly irritable with tetany (spasms of the hands and feet, muscle cramps, abdominal cramps, overly active reflexes, etc.). Chronic calcium deficiency contributes to poor mineralization of bones, soft bones (osteomalacia) and osteoporosis; and, in children, rickets and impaired growth. Food sources of calcium include dairy foods, some leafy green vegetables such as broccoli and collards, canned salmon, clams, oysters, calcium-fortified foods, and tofu. According to the National Academy of Sciences, adequate intake of calcium is 1 gram daily for both men and women. The upper limit for calcium intake is 2.5 grams daily.
(12 Dec 1998)
calcium-dependent protein kinase <enzyme> Mw 51,000; requires ca; not stimulated by calmodulin, phospholipids or diacylglycerol; phosphorylates casein and histones forming primarily phosphoserine and phosphothreonine, respectively
Registry number: EC 2.7.1.-
Synonym: paramecium ca-dependent protein kinase
(26 Jun 1999)
calcium dependent regulator protein <protein> (CDRP) Early name for calmodulin.
(18 Nov 1997)
calcium dependent sulfhydryl protease <enzyme> Hydrolyzes actin binding protein; enzyme from platelets
Registry number: EC 3.4.22.-
Synonym: cdsp
(26 Jun 1999)
calcium, dietary Calcium compounds used as food supplements or in food to supply the body with calcium. Dietary calcium is needed during growth for bone development and for maintenance of skeletal integrity later in life to prevent osteoporosis.
(12 Dec 1998)
calcium dobesilate <chemical> A drug used to reduce haemorrhage in diabetic retinopathy.
Pharmacological action: haemostatics.
Chemical name: Benzenesulfonic acid, 2,5-dihydroxy-, calcium salt (2:1)
(12 Dec 1998)
calcium excess Overly high intake of calcium (hypercalcaemia) may cause muscle weakness and constipation, affect the conduction of electrical impulses in the heart (heart block) lead to calcium stones in the urinary tract, impair kidney function (through nephrocalcinosis), and interfere with the absorption of iron predisposing to iron deficiency. According to the National Academy of Sciences, adequate intake of calcium is 1 gram daily for both men and women. The upper limit for calcium intake is 2.5 grams daily.
(12 Dec 1998)
calcium fluoride <chemical> Calcium fluoride. Occurring in nature as the mineral fluorite or fluorspar. It is the primary source of fluorine and its compounds. Pure calcium fluoride is used as a catalyst in dehydration and dehydrogenation and is used to fluoridate drinking water.
Chemical name: Calcium fluoride (CaF2)
(12 Dec 1998)
calcium folinate <drug> The calcium salt of leucovorin (folinic acid); used to counteract toxic effects of folic acid antagonists, for the treatment of megaloblastic anaemias, and as an adjunct to cyanocobalamin in pernicious anaemia.
Synonym: calcium folinate.
(05 Mar 2000)
calcium glubionate Calcium d-gluconate lactobionate monohydrate;a calcium replenisher.
(05 Mar 2000)
calcium gluceptate Used as a nutrient.
Synonym: calcium glucoheptonate.
(05 Mar 2000)
calcium glucoheptonate Used as a nutrient.
Synonym: calcium glucoheptonate.
(05 Mar 2000)
calcium gluconate <chemical> D-gluconic acid calcium salt (2:1). The calcium salt of gluconic acid. The compound has a variety of uses, including its use as a calcium replenisher in hypocalcaemic states.
Chemical name: D-Gluconic acid, calcium salt (2:1)
(12 Dec 1998)
calcium glycerophosphate A calcium and phosphorus dietary supplement.
(05 Mar 2000)
calcium gout <rheumatology> Chondrocalcinosis, chronic recurrent arthritis clinically similar to gout.
(27 Sep 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á